Contact
    Start Publications Drug-loading capacity of polylactide-based micro- and ...
    ←  Publication Finder
    KSV NIMA

    Drug-loading capacity of polylactide-based micro- and nanoparticles - Experimental and molecular modeling study

    Year: 2020

    Journal: Int. J. Pharm., Volume 591, DEC 15

    Authors: Zatorska, M; Lazarski, G; Maziarz, U; Wilkosz, N; Honda, T; Yusa, S; Bednar, J; Jamroz, D; Kepczynski, M

    Organizations: National Science Centre, PolandNational Science Centre, Poland [2016/21/B/ST5/00250]

    Keywords: All-atom molecular dynamics simulation; Drug-loading capacity; Curcumin loaded polymeric nanoparticles; Polylactide nanoparticles; Drug-polymer matrix interactions; Biodegradable polymers

    Micro- and nanostructures prepared from biodegradable homopolymers and amphiphilic block copolymers (AmBCs) have found application as drug-delivery systems (DDSs). The ability to accumulate a drug is a very important parameter characterizing a given DDS. This work focuses on the impact of DDS size, the packing of polymer chains in the DDS, and drug - polymer matrix compatibility on the hydrophobic drug - loading capacity (DLC) of nano/microcarriers prepared from a biodegradable polymer or its copolymer. Using experimental measurements in combination with atomistic molecular dynamics simulations, an analysis of curcumin encapsulation in microspheres (MSs) from polylactide (PLA) homopolymer and nanoparticles (NPs) from PLA-blockpoly(2-methacryloyloxyethylphosphorylcholine) AmBC was performed. The results show that curcumin has good affinity for the PLA matrix due to its hydrophobic nature. However, the DLC value is limited by the fact that curcumin only accumulates in the peripheral part of these structures. Such uneven drug distribution in the PLA matrix results from the non-homogeneous density of MSs (non-uniform packing of the polymer chains in the coil). The results also indicate that the MSs can retain a greater amount of hydrophobic drug compared to the NPs, which is associated with the formation of drug aggregates inside the PLA microparticles.
    View publication